Status of Diabetes Care: New Challenges, New Concepts, New Measures--Focusing on the Future!
作者信息
Cefalu William T, Boulton Andrew J M, Boulton Andrew J M, Moses Robert G, LeRoith Derek, Greene Eddie L, Hu Frank B, Bakris George, Wylie-Rosett Judith, Rosenstock Julio, Weinger Katie, Blonde Lawrence, de Groot Mary, Riddle Matthew C, Henry Robert, Golden Sherita Hill, Rich Stephen, Reynolds Lyn
出版信息
Diabetes Care. 2015 Jul;38(7):1177-80. doi: 10.2337/dc15-0875.
Abstract
摘要
相似文献
1
Status of Diabetes Care: New Challenges, New Concepts, New Measures--Focusing on the Future!
Diabetes Care. 2015 Jul;38(7):1177-80. doi: 10.2337/dc15-0875.
2
Systematic review of measures and their concepts used in published studies focusing on rehabilitation in the acute hospital and in early post-acute rehabilitation facilities.
Disabil Rehabil. 2005;27(7-8):419-29. doi: 10.1080/09638280400014089.
3
Identifying the concepts contained in outcome measures of clinical trials on four internal disorders using the International Classification of Functioning, Disability and Health as a reference.
J Rehabil Med. 2004 Jul(44 Suppl):37-42. doi: 10.1080/16501960410015407.
4
Searching for Real-World Effectiveness of Health Care Innovations: Scoping Study of Social Prescribing for Diabetes.
J Med Internet Res. 2017 Feb 2;19(2):e20. doi: 10.2196/jmir.6431.
5
Diabetes education: looking through the kaleidoscope.
Clin Ther. 2013 May;35(5):734-9. doi: 10.1016/j.clinthera.2013.02.028.
6
Update on the state of outcome measurement in total elbow arthroplasty research: identifying a need for consensus.
J Bone Joint Surg Am. 2013 Jul 17;95(14):e97 1-8. doi: 10.2106/JBJS.K.01420.
7
Entropic measures of complexity in a new medical coding system.
BMC Med Inform Decis Mak. 2021 Apr 9;21(1):124. doi: 10.1186/s12911-021-01485-y.
8
Patient Reported Outcomes (PROs) used in recent Phase 3 trials for Type 2 Diabetes: A review of concepts assessed by these PROs and factors to consider when choosing a PRO for future trials.
Diabetes Res Clin Pract. 2016 Jun;116:54-67. doi: 10.1016/j.diabres.2016.04.009. Epub 2016 Apr 23.
9
Therapeutic advances in malignant glioma: current status and future prospects.
Neuroimaging Clin N Am. 2009 Nov;19(4):647-56. doi: 10.1016/j.nic.2009.08.015.
10
Special issues in assessing care of Medicaid recipients.
Med Care. 1999 Mar;37(3 Suppl):MS79-88. doi: 10.1097/00005650-199903001-00009.
引用本文的文献
1
Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support.
Med Decis Making. 2019 Apr;39(3):239-252. doi: 10.1177/0272989X19829735. Epub 2019 Feb 15.
2
Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial.
ESC Heart Fail. 2018 Dec;5(6):1035-1043. doi: 10.1002/ehf2.12334. Epub 2018 Aug 17.
3
Diabetes Care: "Lagniappe" and "Seeing Is Believing"!
Diabetes Care. 2016 Jul;39(7):1069-71. doi: 10.2337/dc16-0891. Epub 2016 Jun 9.
4
Building Momentum: Taking on the Real “Issues” of Diabetes Care!
Diabetes Care. 2016 Jan;39(1):10-12. doi: 10.2337/dc15-2315.
本文引用的文献
1
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes.
Diabetes Care. 2015 Jul;38(7):1189-96. doi: 10.2337/dc14-2629. Epub 2015 Jun 6.
2
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Diabetes Care. 2015 Jul;38(7):1181-8. doi: 10.2337/dc14-2806. Epub 2015 Jun 6.
3
Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.
Diabetes Care. 2015 Jul;38(7):1205-11. doi: 10.2337/dc14-3073. Epub 2015 Jun 6.
4
Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.
Diabetes Care. 2015 Jul;38(7):1197-204. doi: 10.2337/dc14-3053. Epub 2015 Jun 6.
5
Weight management in type 2 diabetes: current and emerging approaches to treatment.
Diabetes Care. 2015 Jun;38(6):1161-72. doi: 10.2337/dc14-1630.
6
Type 1 diabetes at a crossroads!
Diabetes Care. 2015 Jun;38(6):968-70. doi: 10.2337/dc15-0615.
7
James R. Gavin III, MD, PhD--a humble and remarkable trailblazer, scientist, advocate, mentor, and educator for diabetes.
Diabetes Care. 2015 Jun;38(6):963-7. doi: 10.2337/dc14-3035.
8
Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.
Diabetes Care. 2015 Jun;38(6):954-62. doi: 10.2337/dc15-0184.
9
2014 presidential address: stop diabetes--it is up to us.
Diabetes Care. 2015 May;38(5):737-42. doi: 10.2337/dc14-2973.
10
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Diabetes Care. 2015 Apr;38(4):716-22. doi: 10.2337/dc15-0168.
Zotero 插件